Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,8694198,Abfw3,Abdominal fat weight QTL 3,16.13,0.001,visceral adipose mass (VT:0010063),abdominal fat pad weight to body weight ratio (CMO:0000095),5,116767924,161767924,Rat,n/a,region,qtl 1000,70202,Alc19,Alcohol consumption QTL 19,2.5,,drinking behavior trait (VT:0001422),ethanol intake volume to total fluid intake volume ratio (CMO:0001591),3,1,28136884,Rat,n/a,region,qtl 1000,8693641,Alc30,Alcohol consumption QTL 30,2,0.739,drinking behavior trait (VT:0001422),calculated ethanol drink intake rate (CMO:0001615),3,5654639,25105730,Rat,n/a,region,qtl 1000,631831,Alc8,Alcohol consumption QTL 8,2.7,,consumption behavior trait (VT:0002069),calculated ethanol drink intake rate (CMO:0001615),3,1,32972944,Rat,n/a,region,qtl 1000,1641912,Alcrsp18,Alcohol response QTL 18,,,response to alcohol trait (VT:0010489),duration of loss of righting reflex (CMO:0002289),5,35788756,147487820,Rat,n/a,region,qtl 1000,2306971,Anxrr21,Anxiety related response QTL 21,9.47,,fear/anxiety-related behavior trait (VT:1000241),number of entries into a discrete space in an experimental apparatus (CMO:0000960),5,65696672,129038896,Rat,n/a,region,qtl 1000,1298526,Arunc3,Aerobic running capacity QTL 3,2.2,,exercise endurance trait (VT:0002332),maximum distance run on treadmill (CMO:0001406),3,2631421,33477544,Rat,n/a,region,qtl 1000,1578673,Bmd13,Bone mineral density QTL 13,4.9,,femur mineral mass (VT:0010011),trabecular volumetric bone mineral density (CMO:0001729),5,107119214,152119214,Rat,n/a,region,qtl 1000,61468,Bp15,Blood pressure QTL 15,4.4,,blood pressure trait (VT:0000183),diastolic blood pressure (CMO:0000005),3,1,28500807,Rat,n/a,region,qtl 1000,61468,Bp15,Blood pressure QTL 15,4.4,,blood pressure trait (VT:0000183),systolic blood pressure (CMO:0000004),3,1,28500807,Rat,n/a,region,qtl 1000,61468,Bp15,Blood pressure QTL 15,4.4,,blood pressure trait (VT:0000183),pulse pressure (CMO:0000292),3,1,28500807,Rat,n/a,region,qtl 1000,1298086,Bp156,Blood pressure QTL 156,,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),5,89502294,134502294,Rat,n/a,region,qtl 1000,1358895,Bp254,Blood pressure QTL 254,3.6,0.0003,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),5,60072951,133313852,Rat,n/a,region,qtl 1000,1358889,Bp261,Blood pressure QTL 261,2.86,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),5,93037304,133313852,Rat,n/a,region,qtl 1000,1598846,Bp293,Blood pressure QTL 293,3.9,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),5,83424556,128424556,Rat,n/a,region,qtl 1000,61393,Bp7,Blood pressure QTL 7,4.5,0.0001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),5,61612600,168109659,Rat,n/a,region,qtl 1000,631545,Bp85,Blood pressure QTL 85,3.1,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),3,1,28500807,Rat,n/a,region,qtl 1000,70191,BpQTLcluster4,Blood pressure QTL cluster 4,3,,arterial blood pressure trait (VT:2000000),absolute change in mean arterial blood pressure (CMO:0000533),3,6000748,51687917,Rat,n/a,region,qtl 1000,70191,BpQTLcluster4,Blood pressure QTL cluster 4,3,,arterial blood pressure trait (VT:2000000),absolute change in systolic blood pressure (CMO:0000607),3,6000748,51687917,Rat,n/a,region,qtl 1000,7207481,Bss106,Bone structure and strength QTL 106,7.9,,femur strength trait (VT:0010010),femur ultimate force (CMO:0001675),5,112279412,157279412,Rat,n/a,region,qtl 1000,7207486,Bss109,Bone structure and strength QTL 109,,,femur strength trait (VT:0010010),femur total energy absorbed before break (CMO:0001677),5,112279412,157279412,Rat,n/a,region,qtl 1000,7207488,Bss110,Bone structure and strength QTL 1,8.4,,femur strength trait (VT:0010010),femur stiffness (CMO:0001674),5,112279412,157279412,Rat,n/a,region,qtl 1000,7207491,Bss112,Bone structure and strength QTL 112,7,,femur morphology trait (VT:0000559),femur midshaft cortical cross-sectional area (CMO:0001663),5,112279412,157279412,Rat,n/a,region,qtl 1000,1549838,Bss4,Bone structure and strength QTL 4,9.2,,femur strength trait (VT:0010010),femur midshaft polar moment of inertia (CMO:0001669),5,112279412,157279412,Rat,n/a,region,qtl 1000,4889966,Bss95,Bone structure and strength QTL 95,4.4,,tibia area (VT:1000281),tibia-fibula cross-sectional area (CMO:0001718),3,1,37891710,Rat,n/a,region,qtl 1000,6893355,Bw101,Body weight QTL 101,0.4,0.38,body mass (VT:0001259),body weight (CMO:0000012),3,6000748,34394365,Rat,n/a,region,qtl 1000,6893363,Bw105,Body weight QTL 105,2.6,0.0036,body mass (VT:0001259),body weight (CMO:0000012),3,6000748,34394365,Rat,n/a,region,qtl 1000,6903316,Bw113,Body weight QTL 113,2,0.0103,body mass (VT:0001259),body weight (CMO:0000012),5,91884213,136884213,Rat,n/a,region,qtl 1000,7411564,Bw135,Body weight QTL 135,,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),5,91585539,136585539,Rat,n/a,region,qtl 1000,8657050,Bw146,Body weight QTL 146,19.84,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),5,113059816,120566842,Rat,n/a,region,qtl 1000,8694389,Bw160,Body weight QTL 160,6.17,0.001,body lean mass (VT:0010483),lean tissue morphological measurement (CMO:0002184),5,116767924,161767924,Rat,n/a,region,qtl 1000,8694441,Bw169,Body weight QTL 169,17.61,0.001,retroperitoneal fat pad mass (VT:0010430),retroperitoneal fat pad weight to body weight ratio (CMO:0000635),5,116767924,161767924,Rat,n/a,region,qtl 1000,1558654,Bw56,Body weight QTL 56,4.5,0.0000171,body mass (VT:0001259),body weight (CMO:0000012),3,6000748,34394365,Rat,n/a,region,qtl 1000,61452,Ciaa5,CIA Autoantibody QTL 5,3.5,,blood autoantibody amount (VT:0003725),calculated serum anti-rat type 2 collagen autoantibody titer (CMO:0001281),5,97921932,149030144,Rat,n/a,region,qtl 1000,631679,Cm10,Cardiac mass QTL 10,7.34,0.0001,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),3,1,25786001,Rat,n/a,region,qtl 1000,1558657,Cm43,Cardiac mass QTL 43,6.6,0.0000000293,heart mass (VT:0007028),heart wet weight (CMO:0000069),3,6000866,34394121,Rat,n/a,region,qtl 1000,1558647,Cm46,Cardiac mass QTL 46,5.4,0.0000055,heart mass (VT:0007028),heart wet weight (CMO:0000069),3,6000866,34394121,Rat,n/a,region,qtl 1000,1558650,Cm48,Cardiac mass QTL 48,4,0.0001,heart mass (VT:0007028),heart weight to body weight ratio (CMO:0000074),3,6000866,34394121,Rat,n/a,region,qtl 1000,1598847,Cm62,Cardiac mass QTL 62,3.4,,heart mass (VT:0007028),heart weight to body weight ratio (CMO:0000074),5,114140832,159140832,Rat,n/a,region,qtl 1000,1598859,Cm66,Cardiac mass QTL 66,2,,heart mass (VT:0007028),heart weight to body weight ratio (CMO:0000074),5,83424556,128424556,Rat,n/a,region,qtl 1000,1358187,Emca1,Estrogen-induced mammary cancer QTL 1,4.4,,mammary gland integrity trait (VT:0010552),post-insult time to mammary tumor formation (CMO:0000345),5,102945579,154732228,Rat,n/a,region,qtl 1000,1576312,Emca8,Estrogen-induced mammary cancer QTL 8,4.1,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),5,51418671,147487820,Rat,n/a,region,qtl 1000,7411601,Foco12,Food consumption QTL 12,19.7,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),5,91585539,136585539,Rat,n/a,region,qtl 1000,7411582,Foco3,Food consumption QTL 3,7.5,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),5,91585539,136585539,Rat,n/a,region,qtl 1000,70203,Gcr2,Gastric cancer resistance QTL 2,2.6,,stomach morphology trait (VT:0000470),stomach tumor susceptibility score (CMO:0002043),3,3285929,28136884,Rat,n/a,region,qtl 1000,2317753,Glom24,Glomerulus QTL 24,3.1,,kidney glomerulus integrity trait (VT:0010546),kidney sclerotic glomeruli count to total glomeruli count ratio (CMO:0001269),5,101265591,141912026,Rat,n/a,region,qtl 1000,1358909,Kidm25,Kidney mass QTL 25,1.87,,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),5,93037304,133313852,Rat,n/a,region,qtl 1000,10401810,Kidm53,Kidney mass QTL 53,,,kidney mass (VT:0002707),both kidneys wet weight as percentage of body weight (CMO:0000140),3,2631421,48562146,Rat,n/a,region,qtl 1000,1582212,Livw2,Liver weight QTL 2,3.5,0.0004,liver mass (VT:0003402),liver weight as percentage of body weight (CMO:0000141),5,102498468,123852688,Rat,n/a,region,qtl 1000,70189,Mcs5,Mammary carcinoma susceptibility QTL 5,10.51,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),5,56991667,137729065,Rat,n/a,region,qtl 1000,70212,Niddm25,Non-insulin dependent diabetes mellitus QTL 25,3.54,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),5,1,136640934,Rat,n/a,region,qtl 1000,8552960,Pigfal15,Plasma insulin-like growth factor 1 level QTL 15,,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),5,116767924,161767924,Rat,n/a,region,qtl 1000,1331801,Rf33,Renal function QTL 33,4.149,,kidney blood vessel physiology trait (VT:0100012),absolute change in renal vascular resistance (CMO:0001900),5,44404276,134502294,Rat,n/a,region,qtl 1000,1298089,Scl14,Serum cholesterol level QTL 14,5.8,0.0004,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),5,114140832,159140832,Rat,n/a,region,qtl 1000,1298070,Scl18,Serum cholesterol level QTL 18,3.7,,blood LDL cholesterol amount (VT:0000181),calculated plasma low density lipoprotein cholesterol level (CMO:0001245),5,83424556,128424556,Rat,n/a,region,qtl 1000,61426,Scl2,Serum cholesterol level QTL 2,7.3,0.001,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),5,61086525,149030144,Rat,n/a,region,qtl 1000,1302790,Scl20,Serum cholesterol level QTL 20,6.4,0.0001,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),5,84963058,173504662,Rat,n/a,region,qtl 1000,1549845,Scl44,Serum cholesterol level QTL 44,6,,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),5,40777918,154732375,Rat,n/a,region,qtl 1000,2290448,Scl54,Serum cholesterol level QTL 54,2.93,,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),5,31926122,136640934,Rat,n/a,region,qtl 1000,2290452,Scl56,Serum cholesterol level QTL 56,2.26,,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),3,1,95176874,Rat,n/a,region,qtl 1000,2312664,Scl62,Serum cholesterol level QTL 62,,0.05,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),3,1,39773425,Rat,n/a,region,qtl 1000,1358357,Srcrtb1,Stress Responsive Cort Basal QTL 1,6.36,0.002,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),3,3285929,28136884,Rat,n/a,region,qtl 1000,1354598,Srn6,Serum renin concentration QTL 6,3.8,,blood renin amount (VT:0003349),plasma renin activity level (CMO:0000116),5,71552569,157225114,Rat,n/a,region,qtl 1000,1578766,Tcas11,Tongue tumor susceptibility QTL 11,4.12,,tongue integrity trait (VT:0010553),number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950),5,47745646,167946134,Rat,n/a,region,qtl 1000,1331796,Thshl2,Thyroid stimulating hormone level QTL 2,2.3,,blood thyroid-stimulating hormone amount (VT:0005119),serum thyroid stimulating hormone level (CMO:0001248),5,100723739,153577831,Rat,n/a,region,qtl 1000,631527,Tls1,T-lymphoma susceptibility QTL 1,0,0.001,thymus integrity trait (VT:0010555),post-insult time to onset of T-cell lymphoma (CMO:0001907),5,93273130,138273130,Rat,n/a,region,qtl 1000,2317056,Wbc3,White blood cell count QTL 3,2.51,0.01,leukocyte quantity (VT:0000217),white blood cell count (CMO:0000027),5,111278451,156278451,Rat,n/a,region,qtl